Sign Up Today and Learn More About Convergent Dental Stock
Invest in or calculate the value of your shares in Convergent Dental or other pre-IPO companies through EquityZen's platform.
Convergent Dental Stock (COND)
Laser-based drilling and cutting system for dentists
About Convergent Dental Stock
Founded
2011
Headquarters
Needham, MA, US
Total Funding
47.5M
Industries
Science and Engineering, Health Care, Biotechnology
Convergent Dental is a privately owned dental equipment and technology company and developer of Sole, the world’s first computer-aided, CO2 laser system to ever be cleared by the FDA for both hard and soft tissue indications. Solea cuts significantly quieter, finer and faster than any other laser-based system in dentistry. Solea’s speed and precision are a result of patented technologies and computer system controls that are unique to Convergent Dental, Inc.
Convergent Dental Press Mentions
Stay in the know about the latest news on Convergent Dental
Convergent Dental Adds Financial Leader Lisa Garrett to Board of Directors
prweb • Aug 08, 2024
Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight
prnewswire • May 19, 2024
Convergent Dental on LinkedIn: #solea #solealaser #teamsolea #soleanation #laserdentistry
linkedin • May 19, 2024
Convergent Dental to Showcase the Solea® All-Tissue Dental Laser at the American Academy of Pediatric Dentistry ...
prweb • May 19, 2024
System and method for laser based treatment of soft tissue
patents • Apr 15, 2024
Investors in Convergent Dental
Discover investors in Convergent Dental stock and explore their portfolio companies
Convergent Dental Management
Leadership team at Convergent Dental
Chief Executive Officer
Michael Cataldo
Chief Financial Officer
Mark Collins
Join now and verify your accreditation status to gain access to:
- Convergent Dental current valuation
- Convergent Dental stock price
- Available deals in Convergent Dental and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Convergent Dental stock?
Accredited investors can buy pre-IPO stock in companies like Convergent Dental through EquityZen funds. These investments are made available by existing Convergent Dental shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Convergent Dental stock?
Shareholders can sell their Convergent Dental stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
